Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

452.42
Delayed Data
As of Apr 20
 +4.90 / +1.09%
Today’s Change
269.50
Today|||52-Week Range
495.50
+10.28%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-221.8M750.3M424.4M348.1M
 
 
 
 
 
Depreciation31.1M36.9M41.2M52.7M
 
 
 
 
 
Total Other Cash Flow66.5M151.1M245.2M388.8M
 
 
 
 
 
Funds From Operations-124.2M598.2M774.3M722.9M
 
 
 
 
 
Funds From/For Other Operating Expenses17.5M672.8M190.7M-20.2M
 
 
 
 
 
Net Cash Flow - Operating Activities-141.7M-74.6M583.6M743.2M
 
 
 
 
 
 
InvestingIncrease In Investments-240.4M-470.4M-577.3M-564.2M
 
 
 
 
 
Decrease In Investments426.4M439.2M378.1M476.4M
 
 
 
 
 
Capital Expenditures-57.2M-49.3M-156.3M-333.0M
 
 
 
 
 
Other Investing - Uses-277.0K-552.0K0.000.00
 
 
 
Net Cash Flow Investing128.5M-81.1M-355.5M-420.8M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings391.1M0.000.000.00
 
 
Long Term Debt Reduction-1.7M-2.2M-2.0M-221.7M
 
 
 
 
 
Net Proceeds Stock Sale112.3M63.5M57.4M126.0M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.004.3M216.9M448.6M
 
 
 
 
Other Uses - Financing117.5M163.3M195.1M562.1M
 
 
 
 
 
Net Cash Flow - Financing384.2M-97.6M77.1M-209.3M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.000.000.000.00--
 
Net Change In Cash371.0M-253.3M305.3M113.1M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account